Travere Therapeutics, Inc. (TVTX)
NASDAQ·Healthcare·Biotechnology
$41.12
+0.76%
Mkt Cap $3.74B
Analyst Ratings
Buy
9
Hold
2
Sell
0
Price Target (17 analysts)
$49.00
Range $49.00 – $49.00
Implied Upside
+19.2%
Consensus $49.00 vs current $41.12
NASDAQ·Healthcare·Biotechnology
$41.12
+0.76%
Mkt Cap $3.74B
Buy
9
Hold
2
Sell
0
Price Target (17 analysts)
$49.00
Range $49.00 – $49.00
+19.2%
Consensus $49.00 vs current $41.12